---
title: ðŸ”„ Open Source Pharma Foundation (OSPF)
description: A global nonprofit promoting open-source drug discovery and development
published: true
date: 2025-05-28T22:23:00.000Z
tags: nonprofit, open-science, drug-development, collaborative-research
editor: markdown
dateCreated: 2025-05-28T22:23:00.000Z
---

# Open Source Pharma Foundation (OSPF)

## Overview
The Open Source Pharma Foundation (OSPF) is a global nonprofit organization that applies open-source principles to pharmaceutical research and development, with a focus on addressing unmet medical needs.

## Key Initiatives
- Promotes open-source approaches to drug discovery and development
- Focuses on repurposing existing drugs for new indications
- Develops open clinical trial methodologies

## Notable Projects
- **Open Source Drug Discovery for TB (OSDD):** Collaborative platform for tuberculosis research
- **Metformin-TB Trial:** Investigating metformin as a treatment for tuberculosis
- **Open Databases:** Creating accessible resources for drug discovery research

## Impact
- Advanced research on tuberculosis treatment through open collaboration
- Demonstrated the potential of open-source approaches in drug development
- Built a model for collaborative, patient-centered research

## Community & Partnerships
- **Community:** Global network of researchers, clinicians, and advocates
- **Key Partners:** Academic institutions, research organizations, and patient groups
- **Collaborators:** Works with traditional pharma in novel ways

## Alignment with dFDA
- **Alignment Level:** High
- Strong alignment on open-science principles
- Focus on patient-centered, collaborative research
- Innovative approaches to drug development that could inform dFDA's work

## Strategic Considerations
- **Strengths:** Innovative model, collaborative approach, focus on neglected diseases
- **Challenges:** Working within existing regulatory frameworks

## Learn More
- [Official Website](https://www.opensourcepharma.net/)
- [OSDD for TB](https://www.osdd.net/)

*Last updated: May 2025*
